Abstract
The annual incidence of colorectal cancer (CRC) in the United States is approximately 131,600.1A positive family history is the most common risk factor for hereditary colon cancer (CRC).2 If one accepts the most conservative estimate that 10% of CRC is hereditary, more than 13,000 of these CRC cases will have a hereditary etiology. The majority of hereditary CRC cases will be hereditary nonpolyposis colorectal cancer (HNPCC), although the exact frequency is not known. Estimates range from a low of about 2% to a high of 10–15% of the total CRC burden. The rare hereditary CRC disorders, such as familial adenomatous polyposis (FAP) and Peutz-Jeghers syndrome (PJS), account for less than 1% of all cases. Table 1 describes hereditary disorders that predispose to CRC.Advancing knowledge may aid in additional molecular genetic diagnoses for hereditary forms of cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Landis SH, Murray T, Bolden S, et al: Cancer statistics, 1998. CA: a Cancer Journal for Clinicians 48:6–29, 1998
Zwick A, Munir M, Ryan CK, et al: Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 113:659–663, 1997
Fuchs C, Giovannucci E, Colditz G, et al: A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331:1669–1674, 1994
St. John JB, McDermott FT, Hopper JL, et al: Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 118:785–790, 1993
Bulow S: Familial polyposis coli. Dan Med Bull 34:1–15, 1987
Luschka H: Ueber polypose Vegetationen der gesammten Dickdarmschleimhaut. Arch Path Anat Phys Klin Med 20:133–142, 1861
Sklifasowski NW: Polyadenoma tractus intestinalis. Vrac 4:55–57, 1881
Cripps WH: Two cases of disseminated polyps of the rectum. Trans Path Soc London 165–168, 1882
Smith T: Three cases of multiple polypi of the lower bowel occurring in one family. St Bartholomew’s Hosp Rep 23:225–229, 1887
Handford H: Disseminated polypi of the large intestine becoming malignant: strictures (malignant adenoma) of the rectum and of the splenic flexure of the colon; secondary growths in the liver. Trans Path Soc London 41:133–137, 1890
Lockhart-Mummery P: Cancer and heredity. Lancet i:427–429, 1925
Lynch HT, Fitzgibbons R, Jr, Chong S, et al: Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner’s syndrome. Dis Colon Rectum 37:260–267, 1994
Lynch HT, Fitzgibbons R, Jr: Surgery, desmoid tumors and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 91:2598–2601, 1996
Groden J, Thliveris A, Samowitz W, et al: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600, 1991
Kinzler KW, Nilbert MC, Su L-K, et al: Identification of FAP locus genes from chromosome 5q21. Science 253:661–665, 1991
Lynch HT, Smyrk T, McGinn T, et al: Attenuated familial adenomatous polyposis (AFAP): a pheno-typically and genotypically distinctive variant of FAP. Cancer 76:2427–2433, 1995
Spirio L, Olschwang S, Groden J, et al: Alleles of the APC gene: an attenuated form of familial polyposis. Cell 75:951–957, 1993
Lynch HT, Smyrk T, Lynch J: Wanebo HJ, editors. Surgery for Gastrointestinal Cancer: A Multidisci-plinary Approach. Philadelphia: Lippincott-Raven Publishers, 1997, 59–86
Burt RW, Bishop DT, Cannon LA, et al: Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 312:1540–1544, 1985
Giardiello FM, Welsh SB, Hamilton SR, et al: Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316:1511–1514, 1987
Jenne DE, Reimann H, Nezu J, et al: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38–44, 1998
Hemminki A, Tomlinson I, Markie D, et al: Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nature Genet 15:87–90, 1997
Olschwang S, Markie D, Seal S, et al: Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19pl3.3. J Med Genet 35:42–44, 1998
Mehenni H, Blouin J-L, Radhakrishna U, et al: Peutz-Jeghers syndrome: confirmation of linkage to chromosome 19pl3.3 and identification of a potential second locus, on 19ql3.4. Am J Hum Genet 61:1327–1334, 1997
Lynch HT, Smyrk T, Lynch J, et al: Genetic counseling in an extended attenuated familial adenomatous polyposis kindred. Am J Gastroenterol 91:455–459, 1996
Lynch ED, Ostermeyer EA, Lee MK, et al: Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am J Hum Genet 61:1254–1260, 1997
Warthin AS: Heredity with reference to carcinoma. Arch Intern Med 12:546–555, 1913
Warthin AS: The further study of a cancer family. J Cancer Res 9:279–286, 1925
Warthin AS: Heredity of carcinoma in man. Ann Int Med 4:681–696, 1931
Lynch HT, Krush AJ: Cancer family “G” revisited: 1895–1970. Cancer 27:1505–1511, 1971
Lynch HT, Shaw MW, Magnuson CW, et al: Hereditary factors in cancer: study of two large midwestern kindreds. Arch Intern Med 117:206–212, 1966
Itoh H, Houlston RS, Harocopos C, et al: Risk of cancer death in first-degree relatives of patients with hereditary nonpolyposis cancer syndrome (Lynch Type II): a study of 130 kindreds in the United Kingdom. Br J Surg 77:1367–1370, 1990
Jass JR, Stewart SM, Schroeder D, et al: Screening for hereditary nonpolyposis colorectal cancer in New Zealand. Eur J Gastroenterol Hepatol 4:523–527, 1992
Vasen HF, Hartog Jager FCA, Menko FH, et al: Screening for hereditary nonpolyposis colorectal cancer: a study of 22 kindreds in the Netherlands. Am J Med 86:278–281, 1989
Ponz de Leon M, Sassatelli R, Sacchetti C, et al: Familial aggregation of tumors in the three year experience of a population-based colorectal cancer registry. Cancer Res 49:4344–4348, 1989
Cristofaro G, Lynch HT, Caruso ML, et al: New phenotypic aspects in a family with Lynch syndrome II. Cancer 60:51–58, 1987
Abusamra H, Maximova S, Bar-Meir S, et al: Cancer family syndrome of Lynch. Am J Med 83:981–981, 1987
Mecklin J-P, Jarvinen HJ, Peltokallio P: Cancer family syndrome: genetic analysis of 22 Finnish kindreds. Gastroenterology 30:328–333, 1986
Mecklin JP: Frequency of hereditary colorectal carcinoma. Gastroenterology 93:1021–1025, 1987
Boland CR, Troncale FJ: Familial colonic cancer without antecedent polyposis. Ann Intern Med 100:700–701, 1984
Lynch HT, Smyrk T: Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review. Cancer 78:1149–1167, 1996
Lynch HT, Smyrk T, Lynch J: An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 93:84–99, 1997
Watson P, Lin K, Rodriguez-Bigas MA, et al: Colorectal carcinoma survival in hereditary nonpolyposis colorectal cancer family members. Cancer 83:259–266, 1998
Sankila R, Aaltonen LA, Jarvinen HJ, et al: Better survival rates in patients with MLHl-associated hereditary colorectal cancer. Gastroenterology 110:682–687,1996
Lynch HT, Albano W, Recabaren J, et al: Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. Med Hypoth 7:1201–1209, 1981
Albano WA, Recabaren JA, Lynch HT, et al: Natural history of hereditary cancer of the breast and colon. Cancer 50:360–363, 1982
Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677–685, 1993
Lynch HT, Fusaro RM, Roberts L, et al: Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome. Br J Dermatol 113:295–301, 1985
Lynch HT, Lynch PM, Pester JA, et al: Lynch HT, Fusaro RM, editors. Cancer-associated Genoder-matoses. New York: Van Nostrand Reinhold, 1982, 366–393
Lynch HT, Fusaro RM: Muir-Torre Syndrome: heterogeneity, natural history, diagnosis, and management. Problems in General Surgery 10:1–14, 1993
Hamilton SR, Liu B, Parsons RE, et al: The molecular basis of Turcot’s syndrome. N Engl J Med 332:839–847, 1995
Fishel R, Lescoe MK, Rao MRS, et al: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027–1038, 1993
Leach FS, Nicolaides NC, Papadopoulos N, et al: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215–1225, 1993
Nicolaides NC, Papadopoulos N, Liu B, et al: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75–80, 1994
Palombo F, Gillinari P, Iaccarino I, et al: GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 268:1912–1914, 1995
Peltomaki P, Aaltonen L, Sistonen P, et al: Genetic mapping of a locus predisposing to human colorectal cancer. Science 260:810–812, 1993
Lindblom A, Tannergard P, Werelius B, et al: Genetic mapping of a second locus predisposing to hereditary nonpolyposis colorectal cancer. Nature Genet 5:279–282, 1993
Ionov YM, Peinado MA, Malkhosyan S, et al: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561, 1993
Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260:816–819, 1993
Tomlinson IPM, Beck NE, Homfray T, et al: Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancer. J Med Genet 34:39–42, 1997
Peltomaki P, Lothe RA, Aaltonen LA, et al: Microsatellite instability is associated with tumors that characterize the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer Res 53:5853–5855, 1993
Aaltonen LA, Peltomaki P, Leach FS, et al: Clues to the pathogenesis of familial colorectal cancer. Science 260:812–816, 1993
Strand M, Prolla TA, Liskay RM, et al: Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365:274–276, 1993
Bronner CE, Baker SM, Morrison PT, et al: Mutation in the DNA mismatch repair gene homologue hMLHl is associated with hereditary nonpolyposis colon cancer. Nature 368:258–261, 1994
Papadopoulos N, Nicolaides NC, Wei Y-F, et al: Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625–1629, 1994
Viel A, Genuardi M, Capozzi E, et al: Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer 18:8–18, 1997
Liu B, Farrington SM, Petersen GM, et al: Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Med 1:348–352, 1995
Liu B, Nicolaides NC, Markowitz S, et al: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 9:48–55, 1995
Miyaki M, Konishi M, Tanaka K, et al: Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17:271–272, 1997
Fujii H, Shimada T: Isolation and characterization of cDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase gene. J Biol Chem 264:10057–10064, 1989
Akiyama Y, Sato H, Yamada T, et al: Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 57:3920–3923, 1997
Peltomäki P, Vasen HFA, International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer: Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. Gastroenterology 113:1146–1158, 1997
Wijnen J, Khan PM, Vasen H, et al: Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet 61:329–335, 1997
Vasen HFA, Wijnen JT, Menko FH, et al: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020–1027, 1996
Lin KM, Shashidharan M, Ternent CA, et al: Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 41:428–433, 1998
Beck NE, Tomlinson IPM, Homfray T, et al: Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg 84:233–237, 1997
Muir EG, Bell AJ, Barlow KA: Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthomata of the face. Br J Surg 54:191–195, 1966
Torre D: Multiple sebaceous tumors. Arch Dermatol 98:549–551, 1968
Lynch HT, Lynch PM, Pester J, et al: The cancer family syndrome: rare cutaneous phenotypic linkage of Torre’s syndrome. Arch Intern Med 141:607–611, 1981
Hall NR, Murday VA, Chapman P, et al: Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome. Eur J Cancer 30A:180–182, 1994
Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al: A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 89:1758–1762, 1997
Liu B, Parsons R, Papadopoulos N, et al: Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients. Nat Med 2:169–174, 1996
International Workshop on Microsatellite Instability and RER Phenotypes in Cancer Detection and Familial Predisposition Meeting. National Cancer Institute; 1997; Bethesda, MD. 1997
Jass JR: Colorectal adenoma progression and genetic change: is there a link? Ann Med 27:301–306, 1995
Winawer SJ, Fletcher RH, Miller L, et al: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112:594–642, 1997
Jass JR, Cottier DS, Pokos V, et al: Mixed epithelial polyps in association with hereditary nonpolyposis colorectal cancer providing an alternative pathway of cancer histogenesis. Pathology 29:28–33, 1997
Jass JR: Familial cancer: histopathological perspectives. J Clin Pathol 50:892–895, 1997
Sheng GG, Shao J, Sheng H, et al: A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology 113:1883–1891, 1997
Elder DJE, Paraskeva C: NSAIDs to prevent colorectal cancer: a question of sensitivity. Gastroenterology 113:1999–2003, 1997
Rodriguez-Bigas MA, Vasen HFA, Pekka-Mecklin J, et al: Rectal cancer risk in hereditary nonpoly-posis colorectal cancer after abdominal colectomy. Ann Surg 225:202–207, 1997
Lynch HT: Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 39:109–110, 1996
Church JM: Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med 28:479–482, 1996
Lynch HT, Cavalieri RJ, Lynch JF, et al: Gynecologic cancer clues to Lynch syndrome II diagnosis: a family report. Gynecologic Oncol 44:198–203, 1992
Lynch HT, Fusaro RM, Lemon SJ, et al: Survey of cancer genetics: genetic testing implications. Cancer 80(suppl):523–532, 1997
Myrhoj T, Bisgaard ML, Bernstein I, et al: Hereditary non-polyposis colorectal cancer: clinical features and survival: results from the Danish HNPCC Register. Scand J Gastroenterol 32:572–576, 1997
Fink D, Aebi S, Howell SB: The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1–6, 1998
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lynch, H.T., Lynch, J.F., Shaw, T.G., Smyrk, T.C. (1999). Genetics of Colorectal Cancer. In: Shaw, G.L. (eds) Cancer Genetics for the Clinician. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4699-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4699-3_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7128-1
Online ISBN: 978-1-4615-4699-3
eBook Packages: Springer Book Archive